Terms ending in 2040
Every in-force patent on Cathay Biotech Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,155,512 | Method and System for Refining Long Chain Dicarboxylic Acid In force · High confidence | Cathay Biotech Inc., Cibt America Inc. and Cathay (Jinxiang) Biomaterial Co., Ltd. | In force | High confidence | |
| US 11,229,881 | Method and System for Extracting Long Chain Dicarboxylic Acid In force · High confidence | Cathay Biotech Inc., Cibt America Inc. and Cathay (Jinxiang) Biomaterial Co., Ltd. | In force | High confidence | |
| US 11,806,670 | Method and System for Extracting Long Chain Dicarboxylic Acid In force · High confidence | Cathay Biotech Inc., Cibt America Inc. and Cathay (Jinxiang) Biomaterial Co., Ltd. | In force | High confidence | |
| US 11,999,689 | Method and System for Extracting Long Chain Dicarboxylic Acid In force · High confidence | Cathay Biotech Inc., Cibt America Inc. and Cathay (Jinxiang) Biomaterial Co., Ltd. | In force | High confidence |
4 of 4 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.